Wegovy 1 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FJ0XT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $32,832
Award facts
- Contract value 100% obligated
- $32,831.69 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp was awarded a $32,831.69 firm fixed price delivery order by the Defense Logistics Agency on April 23, 2025, for the supply of Wegovy 1 mg/0.5 ml pen injections (0.5 ml). The contract, which is neither set-aside nor reserved for any specific business category, will be fulfilled from the vendor's Conshohocken, Pennsylvania location and is scheduled for completion by April 24, 2025. This delivery order represents a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor vehicle valued through December 2026 that enables comprehensive pharmaceutical and medical supply distribution to support military healthcare operations globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a significant federal contract portfolio focused on supplying medications and medical commodities to the Defense Health Agency and broader military healthcare systems. The company consistently competes for and receives awards through open competition for delivery orders across multiple therapeutic domains, including diabetes medications, specialty pharmaceuticals, and medical devices. This particular award for Wegovy, a GLP-1 receptor agonist used in weight management, reflects the company's role as a critical supplier of brand-name pharmaceutical products to federal customers through the DLA's pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DB25FJ0XT?
SPE2DB25FJ0XT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 23, 2025.
How much is contract SPE2DB25FJ0XT worth?
The government has obligated $32,832 on SPE2DB25FJ0XT.
Is contract SPE2DB25FJ0XT an order under another contract?
Yes. SPE2DB25FJ0XT is a delivery order under SPE2DB22D2007, an indefinite delivery contract.
Was contract SPE2DB25FJ0XT competed?
The extent of competition for SPE2DB25FJ0XT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award